Profile of:

Michael Schirmer

Medical studies in Innsbruck until 1984, followed by training in pharmacology, family medicine, internal medicine and rheumatology at the university hospital in Innsbruck, a rehabilitation hospital in Badgastein specialised for rheumatology and at the rheumatology devision of MAYO clinic, Rochester, MN/US. Staff member for rheumatology at the Medical University of Innsbruck since 2000. Clinical research focuses on spondyloarthritis, polymyalgia rheumatic / giant cell arteritis and Behcets disease. Laboratory research focuses on senescent T-cells and role of TLRs in immune-mediated diseases, especially in spondyloarthritis (sponsored by Austrian research fund and FWF et al.). Co-founder and member of the Austrian Spondyloarthritis Task Force (= ASPAT), a working group of the Austrian Society of Gesellschaft für Rheumatologie und Rehabilitation (= ÖGR), with regular activities to provide informations on axial and peripheral spondyloarthritis in Austria.

Full name: Michael Schirmer

Current country: Austria

Membership level: Full

Type of membership: Member

Number of publications: 24

Clinical trials in chronic arthritic diseases with underestimated impact of placebo effects on study size calculation (2023)

Cardiovascular Risks and Risk Stratification in Inflammatory Joint Diseases: A Cross-Sectional Study (2022)

Development of an environmental contextual factor item set relevant to global functioning and health in patients with axial Spondyloarthritis (2021)

Editorial: Initiatives to Reduce Diagnostic Delays in Spondyloarthritis (2021)

Late diagnosis of spondyloarthritis may lead to polypharmacy: A case report (2021)

[Validation of the German translation of the ASAS health index : A questionnaire to assess functioning and health in patients with spondyloarthritis] (2019)

Measurement properties of the ASAS Health Index: results of a global study in patients with axial and peripheral spondyloarthritis (2018)

Measuring impairments of functioning and health in patients with axial spondyloarthritis by using the ASAS Health Index and the Environmental Item Set: translation and cross-cultural adaptation into 15 languages (2016)

[German translation and cross-cultural adaptation of the ASAS health index : An ICF-based instrument for documentation of functional ability in patients with ankylosing spondylitis] (2016)

Premature senescence of T-cell subsets in axial spondyloarthritis (2016)

Fusion of real-time US with CT images to guide sacroiliac joint injection in vitro and in vivo (2010)

Altered T-cell subtypes in spondyloarthritis, rheumatoid arthritis and polymyalgia rheumatica (2010)

[Imaging techniques for early diagnosis of ankylosing spondylitis] (2008)

Diagnostic values of history and clinical examination to predict ultrasound signs of chronic and acute enthesitis (2008)

Feasibility of ultrasound-guided sacroiliac joint injection considering sonoanatomic landmarks at two different levels in cadavers and patients (2008)

High positive predictive value of specific antibodies cross-reacting with a 28-kDa Drosophila antigen for diagnosis of ankylosing spondylitis (2006)

Preferential type 1 chemokine receptors and cytokine production of CD28- T cells in ankylosing spondylitis (2006)

Inflammatory low back pain: high negative predictive value of contrast-enhanced color Doppler ultrasound in the detection of inflamed sacroiliac joints (2005)

Between adaptive and innate immunity: TLR4-mediated perforin production by CD28null T-helper cells in ankylosing spondylitis (2005)

Workshop report: clinical diagnosis and imaging of sacroiliitis, Innsbruck, Austria, October 9, 2003 (2004)

Prevalence, clinical relevance and characterization of circulating cytotoxic CD4+CD28- T cells in ankylosing spondylitis (2003)

Circulating cytotoxic CD8(+) CD28(-) T cells in ankylosing spondylitis (2002)

Vascular endothelial growth factor (VEGF) in ankylosing spondylitis–a pilot study (2002)

Entamoeba hartmanni: a new causative agent in the pathogenesis of reactive arthritis? (1998)